1H-Indole-2-carboxylic acid, 7-amino-5-chloro-, ethyl ester – (59694-51-8)

citalopram hydrobromide, 59729-32-7, Citalopram HBr, Celexa, Cipramil, Elopram, 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile hydrobromide, Seropram, Lu 10-171-B, Citalopram (hydrobromide), CITALOPRAM, HYDROBROMIDE SALT, EINECS 261-890-6, Citalopram (as hydrobromide), NSC-758684, UNII-I1E9D14F36, (S)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile hydrobromide, I1E9D14F36, MFCD02101306, LU-10-171-B, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile hydrobromide, Citalopram.HBr, DTXSID40872344, Citalopram hydrobromide [USAN:USP], 1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide, NSC 758684, 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1, 3-dihydro-5-isobenzofurancarbonitrile hydrobromide, 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1, 3-dihydro-, monohydrobromide, 59729-32-7 (HBr), Citalopram hydrobromide (USAN:USP), Nitalapram HBr, Bonitrile HBr, Prepram HBr, CITALOPRAM HYDROBROMIDE (MART.), CITALOPRAM HYDROBROMIDE [MART.], C20H22BrFN2O, 1-(3-(DIMETHYLAMINO)PROPYL)-1-(P-FLUOROPHENYL)-5-PHTHALANCARBONITRILE MONOHBR, CITALOPRAM HYDROBROMIDE (USP-RS), CITALOPRAM HYDROBROMIDE [USP-RS], 1-(3-DIMETHYLAMINOPROPYL)-1-(4'-FLUOROPHENYL)-1, 3-DIHYDROISOBENZOFURAN-5-CARBONITRILE HBR, 1-(3-DIMETHYLAMINOPROPYL)-1-(4'-FLUOROPHENYL)-1, 3-DIHYDROISOBENZOFURAN-5-CARBONITRILE HYDROBROMIDE, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1, 3-dihydro-2-benzofuran-5-carbonitrile hydrobromide, 5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-1, 3-DIHYDRO-, MONOHBR, SMR000326936, Citalopram hydrobromide [USAN], CITALOPRAM HYDROBROMIDE (EP MONOGRAPH), CITALOPRAM HYDROBROMIDE (USP IMPURITY), CITALOPRAM HYDROBROMIDE [EP MONOGRAPH], CITALOPRAM HYDROBROMIDE [USP IMPURITY], CITALOPRAM HYDROBROMIDE (USP MONOGRAPH), CITALOPRAM HYDROBROMIDE [USP MONOGRAPH], Lu-10-171, SR-01000003129, 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile monohydrobromide, Apertia, Prisdal, Lupram, Sepram, Lu 10-171 HBr, 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile Hydrobromide, Celexa (TN), CPD000326936, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1, 3-dihydro-5-isobenzofurancarbonitrile monohydrobromide, SCHEMBL1118, MLS000758293, MLS000860078, MLS001401376, MLS002222294, Citalopram hydrobromide (USP), CHEBI:3724, CHEMBL1200781, HY-B1287R, MSK10296A, DTXCID60819993, Pharmakon1600-01504172, Citalopram HBr – Bio-X trade mark, HY-B1287, Lu-10-171B, CITALOPRAM HYDROBROMIDE [MI], Tox21_500258, Citalopram (hydrobromide) (Standard), HB2142, NSC758684, s4749, ZD 211, ZD-211, CITALOPRAM HYDROBROMIDE [HSDB], AKOS005145738, AB10921, AC-1595, BCP9000537, CCG-101022, CCG-213271, CITALOPRAM HYDROBROMIDE [VANDF], CS-4735, FC64980, KS-1043, LP00258, NC00272, CITALOPRAM HYDROBROMIDE [WHO-DD], NCGC00093717-01, NCGC00093717-02, NCGC00093717-03, NCGC00260943-01, BC164316, Citalopram hydrobromide, >=98% (HPLC), C2370, CITALOPRAM HYDROBROMIDE [ORANGE BOOK], EU-0100258, NS00088112, C 7861, C75790, D00822, EN300-122615, SBI-0050246.0001, Citalopram.HBr, 1mg/ml in Methanol (as free base), SR-01000003129-2, SR-01000003129-4, Citalopram hydrobromide 100 microg/mL in Acetonitrile, Q27280253, SR-01000003129-10, Z1550648760, Citalopram Hydrobromide 0.1 mg/ml in Methanol (as free base), Citalopram Hydrobromide 1.0 mg/ml in Methanol (as free base), Citalopram hydrobromide, European Pharmacopoeia (EP) Reference Standard, Citalopram hydrobromide, United States Pharmacopeia (USP) Reference Standard, Citalopram for system suitability, European Pharmacopoeia (EP) Reference Standard, Citalopram Hydrobromide, Pharmaceutical Secondary Standard Certified Reference Material, 1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1, 3-dihydro-isobenzofuran-5-carbonitrile hydrobromide, 261-890-6, 5-ISOBENZOFURANCARBONITRILE, 1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1, 3-DIHYDRO-, HYDROBROMIDE (1:1), Citalopram hydrobromide salt Nitalapram LU-10-171, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1, 3-dizohydro-5-isobenzofurancar b onitrile hydrogen bromide salt, Citalopram, hydrobromide salt Nitalapram, LU-10-171, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1, 3-dizohydro-5-isobenzofurancar bonitrile hydrobromide salt